Qunomedical GmbH

Qunomedical is a Berlin-based digital health platform that has been revolutionizing the healthcare industry since its founding in 2015. The company focuses on offering a more humane healthcare experience and streamlining patient relationship management. Qunomedical operates on two fronts: Qunosuite, a Software-as-a-Service (SaaS) for patient relationship management targeting healthcare providers, and Qunomedical, catering to individual patients by connecting them with suitable healthcare providers across various treatment categories.

In November 2022, Qunomedical successfully secured a noteworthy €10 million in series A funding from a consortium of prominent investors including MS&AD Ventures, DvH Ventures, Bertelsmann Investments, and Calm/Storm. This funding is intended to further develop and market Qunosuite, with a focus on the DACH and EU markets, addressing the substantial need for digital advancement in patient acquisition and management.

With operations spanning over 35 countries and serving approximately 10,000 patients monthly, Qunomedical has successfully established a network of reliable healthcare providers. Their seamless process allows patients to request a free quote, receive personalized treatment plans, and obtain assistance with necessary paperwork for their medical journey.

By prioritizing both individual patients and healthcare providers, Qunomedical is making significant strides in driving innovation and efficiency within the healthcare industry, thereby making healthcare more accessible and patient-friendly.